<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32</volume><submitter>Subashi E</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Multiparametric magnetic resonance imaging (MRI) is known to provide predictors for malignancy and treatment outcome. The inclusion of these datasets in workflows for online adaptive planning remains under investigation. We demonstrate the feasibility of longitudinal relaxometry in online MR-guided adaptive stereotactic body radiotherapy (SBRT) to the prostate and dominant intra-prostatic lesion (DIL).&lt;h4>Methods&lt;/h4>Fifty patients with intermediate-risk prostate cancer were included in the study. The clinical target volume (CTV) was defined as the prostate gland plus 1 cm of seminal vesicles. The gross tumor volume (GTV) was defined as the DIL identified on multiparametric MRI. Online adaptive radiotherapy was delivered in a 1.5 T MR-Linac using a prescription of 800 cGy/9</pubmed_abstract><journal>Physics and imaging in radiation oncology</journal><pagination>100678</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11665667</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy.</pubmed_title><pmcid>PMC11665667</pmcid><pubmed_authors>Tyagi N</pubmed_authors><pubmed_authors>Burleson S</pubmed_authors><pubmed_authors>Zelefsky M</pubmed_authors><pubmed_authors>Apte A</pubmed_authors><pubmed_authors>LoCastro E</pubmed_authors><pubmed_authors>Subashi E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy.</name><description>&lt;h4>Purpose&lt;/h4>Multiparametric magnetic resonance imaging (MRI) is known to provide predictors for malignancy and treatment outcome. The inclusion of these datasets in workflows for online adaptive planning remains under investigation. We demonstrate the feasibility of longitudinal relaxometry in online MR-guided adaptive stereotactic body radiotherapy (SBRT) to the prostate and dominant intra-prostatic lesion (DIL).&lt;h4>Methods&lt;/h4>Fifty patients with intermediate-risk prostate cancer were included in the study. The clinical target volume (CTV) was defined as the prostate gland plus 1 cm of seminal vesicles. The gross tumor volume (GTV) was defined as the DIL identified on multiparametric MRI. Online adaptive radiotherapy was delivered in a 1.5 T MR-Linac using a prescription of 800 cGy/9</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-04T20:28:49.284Z</modification><creation>2025-04-04T20:28:49.284Z</creation></dates><accession>S-EPMC11665667</accession><cross_references><pubmed>39717186</pubmed><doi>10.1016/j.phro.2024.100678</doi></cross_references></HashMap>